A multi-site study, backed by an $8 million NIH grant, will evaluate the effectiveness of Lucid Diagnostics' EsoCheck and ...

Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

Kim Kardashian's attempt at reuniting her famous family with an item connected to her late dad is proving difficult.

Alcohol is considered a group one carcinogen.50% increase in ER visits related to alcohol use, especially among middle age ...

Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development of gastric cancer-among the world's deadliest forms of the disease.

Ken Kato, MD, PhD, and Harry H. Yoon, MD, MHS, discussed the recent FDA approval of tislelizumab in the first line for patients with esophageal squamous cell carcinoma.

Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development ...

Lucid Diagnostics (LUCD) announced that Highmark Blue Cross Blue Shield, an independent licensee of the Blue Cross and Blue Shield Association, ...

According to Amanda, both children have faced challenges in adapting. Peyton is still grappling with the loss of another ...

The mRNA technology behind coronavirus vaccines is now being used to create bespoke vaccines for cancer patients.

Excessive alcohol consumption is a significant public health concern, responsible for approximately 6% of all deaths and ...